Maternal / Infant Health Seed R&D Grant Program

Maternal / Infant Health Seed R&D Grant Program is sponsored by New Jersey Commission on Science, Innovation, and Technology (CSIT). This grant engages early-stage innovation-based companies in New Jersey to accelerate the R&D of technologies to transform new discoveries from the research stage into commercially viable products and services that impact maternal and infant health.

» Maternal and Infant Grant Program, Round 2 MATERNAL AND INFANT HEALTH GRANT PROGRAM, ROUND 2 The Maternal and Infant R&D Grant Program Round 2 application is now closed. The Maternal and Infant R&D Grant Program Round 2 is a $1,550,000 pilot program. Eligible applicants can apply for seed grant up to $75,000 to support innovations that address maternal and infant health challenges in New Jersey.

The grant will engage early-stage innovation-based companies in New Jersey and help to accelerate research and development of technologies, transforming new discoveries from research stage into commercially viable products and services. Investing in research and new technologies strengthens our families by ensuring the health and safety of mothers and their babies.

I’m thrilled the Maternal and Infant Health R&D Seed Grant Program will advance our work to end racial disparities by funding New Jersey companies committed to supporting maternal and infant health through innovation.

-New Jersey First Lady Tammy Murphy The goal of the Maternal and Infant Health R&D Grant Program is to support innovation from researchers and entrepreneurs focused on developing technology, therapeutics, and other solutions to address maternal and infant health challenges in New Jersey.

The grant will engage early-stage innovation-based companies in NJ to accelerate research and development of technologies to transform new discoveries from research stage into commercially viable products and services that impact maternal and infant health.

The grant funds support the R&D development of technologies, products and services that enhances the quality of care and service delivery activities to women, infants, and healthcare agencies. The program focuses on outcomes that increase positive health outcomes throughout the Continuity of Care Stage: Prenatal through Postpartum.

The objectives of the program are to: support innovation from researchers and entrepreneurs focused on developing technology, therapeutics, and other solutions to address maternal and infant health challenges from prenatal to 12 months postpartum; and engage early-stage innovation-based companies in NJ to accelerate research and development of technologies to transform new discoveries from research stage into commercially viable products and services that impact maternal and infant health The Maternal and Infant Health R&D Grant Program is for companies conducting research and development or testing technologies in the following target areas: Life Sciences – (e.g., therapeutic drug development, medical device) Technology (e.g., digital and telehealth services and platform development) Food and beverage (non-retail) Eligible applicants can propose a project of up to one year in duration and with a maximum budget of $75,000.

Grants will be awarded on a competitive basis, with awards going to the highest scoring applicants provided the minimum score is met. Each approved grant will be valid for a period of 12 months (starting from date of the execution of the grant agreement). Any unused approved grant amounts will be cancelled after the 12 month period and returned to the program budget for future use.

All applicants must meet the following eligibility criteria at the time of submission and throughout the application review period: Be authorized and in good standing to conduct business in NJ. Have a current valid NJ tax clearance certificate addressed to New Jersey Commission on Science, Innovation and Technology. All certificates listing another state agency will be rejected.

Have no more than 50 full-time equivalent (“FTE”) workers (FTE is calculated on a 35-hour work week) at time of application. Have a minimum of one (1) full-time worker (35 hours work week. A founder can be counted as a worker; a worker may be paid or unpaid.

Have a minimum of one full-time workers (35 hours per week basis). A founder can be counted as a worker, and a worker may be paid or unpaid. Fifty percent or more of the cumulative hours worked by all workers, founders, and contractors must be conducted in NJ (as calculated on an FTE basis of 35 hours per week).

Have less than or equal to five million dollars ($5,000,000) in prior calendar year sales revenue (excluding grant revenue). The grant funding can be utilized to maintain R&D activities and cover general operating costs.

The grant funding cannot be utilized for the following Direct counseling and clinical service projects Manufacturing of products for sale or commercial use Real estate rental expenses Patient clinical trial expenses Eligible applicants can receive grant awards of up to $75,000. The online application will launch at 9am on Monday, June 17, 2024 and will be accepted through Friday, July 26, 2024 at 5pm.

Board Memo and Spec Sheet Webinar Slide Deck Budget and Milestone NOTICE OF FUNDING AVAILABILITY SAMPLE APPLICATION How to Obtain a Tax Clearance Frequently Asked Questions (FAQs) Please email: csitmaternal@www. njcsit. gov